logo
Select company
Select metric
$ 14.48MNet Cash Flow - Financing
VS
Market
30
Sector
36
Industry
44
History
33
$ 1.34Close
$ 0.55 - $ 2.35 52-Week Range
Ticker Information

Ticker

CNTX

Company Name

CONTEXT THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CONTEXT THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CNTX - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 14.48M
3/31/2025$ 14.48M
12/31/2024$ 109.29M
9/30/2024$ -44.63K
6/30/2024$ 0
3/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CONTEXT THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 1.15M.
  • Over the past 5 years, CONTEXT THERAPEUTICS INC's average CF - Financing has been $ 22.52M.
  • The median CF - Financing for CONTEXT THERAPEUTICS INC during this period was $ 574.53K
  • CONTEXT THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 109.29M.
  • The lowest CF - Financing recorded by CONTEXT THERAPEUTICS INC in the same timeframe $ -102.07K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

CNTX - Net Cash Flow - Financing, Last 5 years

$ -102.07K

Minimum

Dec 31, 2022

$ 109.29M

Maximum

Dec 31, 2024

$ 22.52M

Average

$ 574.53K

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.94M with a standard deviation of $ 118.72M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.22K
min$ -365.75M
max$ 365M
average$ -6.94M
median$ 305.91K
std$ 118.72M